Statement by Calliditas Therapeutics Board on Asahi Kasei Corporation Public Offer

Tuesday, 28 May 2024, 04:24

The Board of Directors of Calliditas Therapeutics AB released a statement regarding the public offer made by Asahi Kasei Corporation. The statement outlines the position of Calliditas Therapeutics in response to the offer and sheds light on the implications for the company moving forward.

https://store.livarava.com/4591275d-1cc5-11ef-a3da-9d5fa15a64d8.jpg — Statement by Calliditas Therapeutics Board on Asahi Kasei Corporation Public Offer

Statement by the Board of Directors of Calliditas Therapeutics AB (publ) in relation to the public offer by Asahi Kasei Corporation

The Board of Directors of Calliditas Therapeutics AB has issued a statement in response to the public offer made by Asahi Kasei Corporation. The statement addresses the details of the offer and the considerations taken by the board in evaluating it.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.